Beate Klimm

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Bastian von Tresckow, Annette Plütschow, Michael Fuchs et al. · Journal of Clinical Oncology · 2012 · 311 citations · Full text

Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group

Karolin Behringer, Kai Breuer, Thorsten Reineke et al. · Journal of Clinical Oncology · 2005 · 298 citations · Full text

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Peter Borchmann, Annette Plütschow, Carsten Kobe et al. · The Lancet Oncology · 2021 · 153 citations

Lymphoid Neoplasia, Radiation Therapy, Pet-guided Omission +8

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp et al. · Blood · 2014 · 136 citations

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

Dennis A. Eichenauer, Michael Fuchs, Annette Pluetschow et al. · Blood · 2011 · 117 citations · Full text